Your browser doesn't support javascript.
loading
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
Cabasag, Citadel J; Butler, John; Arnold, Melina; Rutherford, Mark; Bardot, Aude; Ferlay, Jacques; Morgan, Eileen; Møller, Bjørn; Gavin, Anna; Norell, Charles H; Harrison, Samantha; Saint-Jacques, Nathalie; Eden, Michael; Rous, Brian; Nordin, Andy; Hanna, Louise; Kwon, Janice; Cohen, Paul A; Altman, Alon D; Shack, Lorraine; Kozie, Serena; Engholm, Gerda; De, Prithwish; Sykes, Peter; Porter, Geoff; Ferguson, Sarah; Walsh, Paul; Trevithick, Richard; Tervonen, Hanna; O'Connell, Dianne; Bray, Freddie; Soerjomataram, Isabelle.
Afiliación
  • Cabasag CJ; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France. Electronic address: CabasagC@fellows.iarc.fr.
  • Butler J; Royal Marsden Hospital, Fulham Road, London SW3 6JJ, England, UK.
  • Arnold M; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France.
  • Rutherford M; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France; Biostatistics Research Group, Department of Health Sciences, University of Leicester, University Road, Leicester LE1 7RH, UK.
  • Bardot A; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France.
  • Ferlay J; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France.
  • Morgan E; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France; Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Møller B; Cancer Registry of Norway, Institute of Population-based Cancer Research, P.O. Box 5313, Majorstuen, 0304 Oslo, Norway.
  • Gavin A; Northern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
  • Norell CH; Policy & Information Directorate, Cancer Research UK, London, England, UK.
  • Harrison S; Policy & Information Directorate, Cancer Research UK, London, England, UK.
  • Saint-Jacques N; Nova Scotia Health Authority Cancer Care Program, Registry & Analytics, 1276 South Street, Halifax B3H 2Y9, NS, Canada.
  • Eden M; National Cancer Registrations and Analysis Service, Public Health England, Wellington House, London, UK.
  • Rous B; National Cancer Registrations and Analysis Service, Public Health England, Wellington House, London, UK.
  • Nordin A; East Kent Hospitals University National Health Service Foundation Trust, Kent, England, UK.
  • Hanna L; Velindre University National Health Service Trust, Cardiff, Wales, UK.
  • Kwon J; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of British Columbia, Vancouver, British Columbia, Canada; BC Cancer, Department of Surgical Oncology, Vancouver, British Columbia, Canada.
  • Cohen PA; University of Western Australia, Division of Obstetrics and Gynaecology, Crawley, Western Australia, Australia; St John of God Subiaco Hospital, Subiaco, Western Australia, Australia.
  • Altman AD; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
  • Shack L; Cancer Control Alberta, Alberta Health Services, 2210 2nd Street, SW, Calgary, AB T2S 3C3, Canada.
  • Kozie S; Registry Department, Saskatchewan Cancer Agency, Regina, SK S4W 0G3, Canada.
  • Engholm G; Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen, Denmark.
  • De P; Surveillance & Cancer Registry, Cancer Care Ontario, 620 University Ave., Toronto, ON M5G 2L7, Canada.
  • Sykes P; University of Otago, Christchurch, New Zealand.
  • Porter G; Canadian Partnership Against Cancer, 145 King Street West, Suite 900, Toronto, Ontario M5H 1J8, Canada.
  • Ferguson S; Gynecologic Oncology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.
  • Walsh P; National Cancer Registry Ireland, Cork Airport Business Park, Kinsale Road, Cork T12 CDF7, Ireland.
  • Trevithick R; Western Australia Cancer and Palliative Care Network Policy Unit, Health Networks Branch, Department of Health, Perth, Western Australia, Australia.
  • Tervonen H; Cancer Institute NSW, PO Box 41, Alexandria NSW 1435, Australia.
  • O'Connell D; Cancer Research Division, Cancer Council NSW, Sydney, New South Wales, Australia.
  • Bray F; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France.
  • Soerjomataram I; Section of Cancer Surveillance, International Agency for Research on Cancer (IARC/WHO), 150 Cours Albert Thomas, Lyon 69372 CEDEX 08, France.
Gynecol Oncol ; 157(1): 234-244, 2020 04.
Article en En | MEDLINE | ID: mdl-32005583
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma Epitelial de Ovario Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma Epitelial de Ovario Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte / Europa / Oceania Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article